PPIs linked to infectious gastroenteritis
Doctors need to be aware of a higher risk of gastroenteritis when prescribing PPIs, say Australian researchers.
Data from nearly 40,000 people in the 45 and Up study showed a 70% increased risk of hospitalisation for infectious gastroenteritis in people using PPIs.
There was a dose–response relationship, with those on the highest doses more than doubling their risk of gastroenteritis compared with non-users.
People with chronic bowel problems were more likely to be on PPIs and were also at greatest risk of a gastro hospitalisation, the researchers from the ANU and the Sax